Uptrend Call Working As Natus Medical Stock Rises 60.6% (BABY)
Comtex SmarTrend(R) - Fri Apr 11, 4:48PM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 6 months, Natus Medical has returned 60.61% as of today's recent price of $23.16.
U.S. Market for Female and Neonatal Diagnostic Devices - 10 Year Forecasts for the $1 Billion Industry
M2 - Thu Apr 10, 8:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/75j8xj/u_s_market_for) has announced the addition of the "U.S. Market for Female and Neonatal Diagnostic Devices" report to their offering. In 2012, the U.S. market for female and neonatal diagnostic devices was valued at over $1 billion. This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, fetal and neonatal monitoring, infant warmers and incubators. The majority of these market segments will see stable growth throughout the forecast period of this report, despite slow national economic growth. In 2012, the largest segment of this market was represented by breast imaging. This is primarily due to the large number of screening procedures performed with these devices, which add to the demand of the device. Moreover, the ASP of these devices is high in comparison to the devices from other markets discussed in this report. This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S. market. Main Segments Included: - U.S. Female and Neonatal Diagnostic Device Market - Bone Densitometry Market - Breast Biopsy Device Market - Breast Imaging Market - Obstetrics and Genecology Ultrasound Market - Fetal and Neonatal Monitoring Market - Infant Warmer and Incubator Market Key Topics Covered: - U.S. Markets For Female And Neonatal Diagnostic Devices - Full Suite Executive Summary - Research Methodology - U.S. Female And Neonatal Diagnostic Device Market Overview - Bone Densitometry Market - Breast Biopsy Device Market - Breast Imaging Market - Obstetrics And Gynecology Ultrasound Market - Fetal And Neonatal Monitoring Device Market - Infant Warmer And Incubator Market - Appendix I: Gynecological Chair Market - Appendix II: Breast Tomosynthesis Companies Mentioned - C. R. Bard - CareFusion - Cooper Surgical - Devicor Medical Products - Dilon Technologies - Draeger Medical - Fujifilm Medical Systems - GE Healthcare - Hitachi-Aloka Medical Systems America - Hollister - Intact Medical - International Biomedical - Lone Oak Medical Technologies - Machnet B.V. - Natus Medical - Naviscan - Osteometer MediTech - Philips Healthcare - Philips Medical Systems - SRS Medical - Samsung Medison - Scion Medical Technologies - Siemens Healthcare - Smith & Nephew - Smiths Medical - Spacelabs Healthcare - Stryker - Sunlight Medical (Wallach Surgical) - Supersonic - Welch Allyn For more information visit http://www.researchandmarkets.com/research/75...market_for
Natus Medical to Hold 2014 First Quarter Financial Results Conference Call on April 23rd
Business Wire - Wed Apr 09, 6:30AM CDT
Natus Medical Incorporated (NASDAQ: BABY) today announced that the Company will release its 2014 first quarter financial results before the market opens on Wednesday, April 23. Natus management will host an investment-community conference call the same day beginning at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to discuss those results and to answer questions.
Electrodes for Medical Devices - Global Strategic Business Report 2014
M2 - Tue Apr 08, 8:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vg6kh7/electrodes_for) has announced the addition of the "Electrodes for Medical Devices - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Electrodes for Medical Devices in US$ Thousand by the following Product Segments: Blood Gas Electrodes, Defibrillator Electrodes, ECG Electrodes, EEG/EMG/ENG Electrodes, Electrosurgical Electrodes, Ion-selective Electrodes, pH Electrodes, Pacemaker Electrodes, and TENS Electrodes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 111 companies including many key and niche players such as: - 3M Company - Ambu A/S - CONMED Corporation - Covidien - C.R Bard, Inc. - Katecho, Inc. - Leonhard Lang GmbH - Natus Medical Incorporated - Nikomed USA, Inc. - Philips Healthcare - Prosurg, Inc. - Rhythmlink International, LLC - Utah Medical Products Inc. - ZOLL Medical Corporation Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. OUTLOOK 2. MARKET DYNAMICS & TRENDS 3. PRODUCT OVERVIEW 4. PRODUCT INTRODUCTIONS/INNOVATIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT PLAYERS 7. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. THE MIDDLE EAST 7. LATIN AMERICA IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 111 (including Divisions/Subsidiaries 125) - The United States (85) - Canada (4) - Japan (2) - Europe (31) - France (2) - Germany (
Uptrend Call Working As Natus Medical Stock Rises 78.4% (BABY)
Comtex SmarTrend(R) - Fri Apr 04, 11:00AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 6 months, Natus Medical has returned 78.43% as of today's recent price of $25.73.
Financial Results, Launches, Adjusted Conversion Rates, Upcoming Presentations, and Stock Movements - Analyst Notes on AbbVie, Chemed, Antares Pharma, Magellan Health Services, and Natus Medical
PR Newswire - Thu Apr 03, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding AbbVie Inc. (NYSE: ABBV), Chemed Corp. (NYSE: CHE), Antares Pharma Inc. (NASDAQ: ATRS), Magellan Health Services Inc. (NASDAQ: MGLN), and Natus Medical Inc. (NASDAQ: BABY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Shares of BABY Up 72.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Mar 28, 9:38AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 6 months, Natus Medical has returned 72.12% as of today's recent price of $24.82.
ABIOMED's Impella Trial Achieves Enrollment Target - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 2:20PM CDT
On reaching the enrollment target, ABIOMED plans to submit the compiled data and seek FDA approval for a Continuous Access Protocol.
Uptrend Call Working As Natus Medical Stock Rises 83.1% (BABY)
Comtex SmarTrend(R) - Fri Mar 21, 9:10AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 6 months, Natus Medical has returned 83.15% as of today's recent price of $26.41.
Veracyte (VCYT) Jumps: Stock Rises 8.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 8:21AM CDT
Veracyte, Inc. (VCYT) was a big mover last session, as the company saw its shares rise by over 8% on the day.
FDA Expands Angiovac Clearance for AngioDynamics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 17, 10:42AM CDT
The expanded clearance for AngioVac cannula seems reasonable given the wide acceptance of the product across the U.S.
Varian Exhibits Imaging Components - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 17, 9:14AM CDT
The exhibits put up by VAR was inclusive of the company's PaxScan wireless digital detectors, digital image processing systems as well as its full range of X-ray tubes for mammography, fluoroscopy, angiography, cardiology and cone beam CT imaging.
Meridian to Deploy Varian's TrueBeam Technology - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 3:30PM CDT
Varian's shares, which are up around 14% over a year, rose 1.4% in the trading session following the news release.
Balanced View on Intuitive Surgical - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 2:00PM CDT
Intuitive Surgical continues to see pressure on gynecology surgery, dispute related to some da Vinci procedures and changing capital spending priorities in hospitals due to the implementation of the Affordable Care Act.
LDR Holding's Shares Hit 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 1:39PM CDT
LDR Holding's shares reached a 52-week high following the approval of Category I code.
AngioDynamics Raised to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 11:00AM CDT
A promising guidance, an innovative pipeline and management's efforts to leverage operational activities represent a potential upside for AngioDynamics going forward.
Natus Medical Shares Up 79.8% Since SmarTrend's Buy Recommendation (BABY)
Comtex SmarTrend(R) - Thu Mar 13, 4:39PM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 5 months, Natus Medical has returned 79.82% as of today's recent price of $25.93.
Mindray Medical Sees Continued International Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 2:10PM CDT
MR delivered positive earnings surprise in each of the last four quarters
Cancer Center Uses Varian Medical's Radiosurgery System - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 1:50PM CDT
VAR's Calypso "GPS for the Body" enables targeting precision for tracing tumor position in real time.
AngioDynamics (ANGO) in Focus: Stock Moves 5.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 8:18AM CDT
AngioDynamics Inc. (ANGO) was a big mover last session, as the company saw its shares rise by roughly 6% on the day.